Alithea Bio
Freiburg im Breisgau, Germany
Alithea Bio is a pioneering healthcare startup focused on revolutionizing cancer treatment through precision immunotherapy. The company specializes in HLA peptide characterization, utilizing cutting-edge immunopeptidomics, highly sensitive mass spectrometry, and AI-driven analytics to enhance therapeutic solutions for patients. Alithea Bio's offerings include the HLA-Compass database with over 1.4 million unique peptides, proprietary mass spectrometry services such as NeoZOOM for ultra-sensitive profiling, and robust off-target toxicity prediction tools. Committed to advancing the field of immunotherapy, Alithea Bio aims to provide safer and more effective cancer treatments by leveraging innovative TCR therapies and comprehensive HLA peptide databases.
Company Info
- Founded
- 2019
- Website
- alithea-bio.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Alithea Bio?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.